Quintiles

Cequent Pharmaceuticals, a privately held biopharmaceutical company based in Cambridge, Massachusetts, is at the forefront of developing novel therapeutics aimed at preventing and treating a variety of human diseases, including inflammatory diseases and cancer. Established in 2006, the company leverages its proprietary TransKingdom RNA interference (tkRNAi) technology to target specific disease-causing genes safely and effectively using non-pathogenic bacteria as delivery vehicles. The tkRNAi platform enables the development of drug candidates that can silence one or more cellular genes simultaneously, offering a powerful alternative to traditional small molecules and monoclonal antibodies. With its foundation rooted in groundbreaking scientific research from the Institut Pasteur in Paris and Beth Israel Deaconess Medical Center at Harvard Medical School, Cequent is poised to make significant advancements in the biopharmaceutical landscape. Generated from the website

Ironwood Pharmaceuticals is a leading healthcare company dedicated to advancing the treatment of gastrointestinal (GI) diseases and redefining the standard of care for patients affected by these conditions. With one in five Americans suffering from GI diseases, Ironwood's innovations aim to alleviate the significant healthcare burden associated with these ailments. The company focuses on GI drug discovery, leveraging deep insights into the unique patient journey to enhance therapeutic outcomes. By fostering a culture of collaboration and innovation, Ironwood strives to improve the quality of life for patients through compassionate and scientifically-driven solutions. Generated from the website

The Cryogenic Institute of New England, Inc. in Worcester, MA offers a range of cryogen-driven solutions to enhance the quality, performance, and reliability of parts and equipment for their customers. Their services include cryogenic deflashing and deburring, dry ice blasting, cryogenic treatment, and part-enhancing cryogenic processes. With a focus on serving, enabling, and empowering others, the Cryogenic Institute of New England is dedicated to making a difference through their innovative cryogenic solutions. They are ITAR registered and NIST 800-171 certified, making them a trusted choice for companies in the defense supply chain.Generated from the website